Protocol No.: 11VR1.1; A Blinded Placebo Controlled Single Ascending Dose Phase 1 for Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Subcutaneous Administration of VRS-317 in Adults with Growth Hormone Deficiency

Project: Other project

StatusFinished
Effective start/end date10/21/1110/20/13

Funding

  • Versartis Incorporated: $6,918.40